Merck & Co said on Tuesday it was planning to produce and donate investigational Sudan ebolavirus vaccine to a global non-profit organization's research program in Uganda, which is facing an outbreak of the disease. Read More ...
Continue reading the above news article, by clicking here.
Administration and Moderation NOTE: A Reminder, the above news is provided for free, through a RSS Feed. The above quote does NOT include the full story. In order to continue to read more past what is quoted, please click through to the article, by clicking on the link provided above through the "continue reading" text.
Please be sensible and follow our terms of service and rules, when replying and debating the news article.